Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial

Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998–2008)

(2012) S. R. Majumdar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis

(2012) Anthony J Avery et al.   LANCET

Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis

(2011) M.-C. Laliberté et al.   OSTEOPOROSIS INTERNATIONAL

The impact of pharmacist interventions on osteoporosis management: a systematic review

(2011) M. N. Elias et al.   OSTEOPOROSIS INTERNATIONAL

Drug-induced Osteoporosis: Mechanisms and Clinical Implications

(2010) Gherardo Mazziotti et al.   AMERICAN JOURNAL OF MEDICINE

Prevalence and determinants of pharmacy shopping behaviour

(2010) H. Buurma et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial

(2009) N. Yuksel et al.   OSTEOPOROSIS INTERNATIONAL